Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Urinary excretion of 11-dehydro thromboxane B2 (Tx-M) in patients on fradafiban alone, aspirin alone, or aspirin plus nimesulide prior to and at selected intervals during and following percutaneous transluminal coronary angioplasty (PTCA). Urinary Tx-M was higher in the fradafiban group prior to PTCA than in normal subjects (p < 0.05) and increased markedly during the procedure compared with aspirin alone (p < 0.0001).
|
